Making Sure That Orphan Incentives Tip the Right Way in Europe

The delicate balance of funding research and development of treatments for rare disease is only imperfectly achieved in Europe, and even the current provisional equilibrium is under a new threat from well-intentioned policy changes now in prospect that could—in addition to the intrinsic complexities...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Denis, Koeva-Balabanova, Jasmina, Capoluongo, Ettore, Jagielska, Beata, Cattaneo, Ivana, Kozaric, Marta, Tumiene, Birute, El Ahl, Jean-Paul, Lal, Jonathan A., Kalra, Dipak, Malats, Núria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498781/
https://www.ncbi.nlm.nih.gov/pubmed/36141212
http://dx.doi.org/10.3390/healthcare10091600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498781/
https://www.ncbi.nlm.nih.gov/pubmed/36141212
http://dx.doi.org/10.3390/healthcare10091600

Ejemplares similares